News

July 24, 2020July 24, 2020

sJIA Patients May Benefit More From Biologics Than Non-systemic, Review Finds

News

Biological therapies or biologics may be more beneficial for young people with systemic juvenile idiopathic arthritis (sJIA) than for those with non-systemic disease, according to a review study. The ... Read more

July 17, 2020July 17, 2020

Fundraisers and Fun Mark July, Juvenile Arthritis Awareness Month

News

With a goal of dispelling the common notion that only seniors get arthritis, Juvenile Arthritis Awareness Month efforts are underway. The juvenile arthritis community is observing the annual July event, organized ... Read more

July 10, 2020July 10, 2020

Hulio, Biosimilar of Humira, Wins FDA Approval for JIA, But Not Available Until 2023

News

The U.S. Food and Drug Administration (FDA) has approved Hulio, a biosimilar of Humira (adalimumab), for the treatment of juvenile idiopathic arthritis (JIA) in individuals ages 4 and older. However, the biosimilar ... Read more

June 19, 2020June 19, 2020

MEFV Gene Mutation May Be Risk Factor for sJIA, Study Suggests

News

A specific mutation in the MEFV gene, which has been linked to inflammation, may be a risk factor for developing systemic juvenile idiopathic arthritis (sJIA), a study in China ... Read more

June 12, 2020June 12, 2020

Enbrel Biosimilar Nepexto Approved in Europe for JIA, Other Inflammatory Disorders

News

The European Commission has approved Nepexto, a biosimilar of Enbrel (etanercept), for the treatment of juvenile idiopathic arthritis and other inflammatory disorders. Nepexto is expected to be available to patients in the European ... Read more

June 5, 2020June 5, 2020

Teens in Netherlands Can Disregard Disease in Planning for Future, Survey Finds

News

Teenagers with juvenile idiopathic arthritis (JIA) in the Netherlands show a desire for “normalcy” and willingness not to consider their disease in career plans, voicing in a survey hopes ... Read more

May 29, 2020May 29, 2020

Nearly One-fifth of Infections Opportunistic in JIA Children on Immunosuppressants, Study Reports

News

Close to one-fifth of infections in children with juvenile idiopathic arthritis (JIA) on immunosuppressants are caused by opportunistic pathogens — such as microorganisms that take advantage of weakened immune ... Read more

May 22, 2020May 22, 2020

Short Film on Woman with Juvenile Arthritis Highlights Awareness Month

News

A new short film called “Joint Effort” traces the journey of Zoe Zeerip, a Michigan woman who was diagnosed with juvenile idiopathic arthritis (JIA) at age 13. “At such ... Read more

May 21, 2020May 21, 2020

Video Games Connect Chronically Ill Children Isolated at Home, Hospital

cystic fibrosis, News, syndicated

Dara Riva always had a rule that her 10-year-old son could play video games only once a week. But then the COVID-19 pandemic struck, and her perspective changed. Riva’s ... Read more

May 15, 2020May 15, 2020

Janssen Seeks FDA Approval for Simponi Aria in JIA Subtypes

News

Janssen has submitted two new applications to the U.S. Food and Drug Administration (FDA) seeking approval for Simponi Aria (golimumab), in combination with methotrexate, for the treatment of polyarticular juvenile ... Read more

Pin It on Pinterest